Upload folder using huggingface_hub
Browse filesThis view is limited to 50 files because it contains too many changes.
See raw diff
- .gitattributes +25 -0
- downloads_2025_onwards/1000228_2025-02-05_HENRY_SCHEIN_INC_3/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-02-05_HENRY_SCHEIN_INC_3/ownership.html +226 -0
- downloads_2025_onwards/1000228_2025-02-05_HENRY_SCHEIN_INC_3/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-02-21_HENRY_SCHEIN_INC_3/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-02-21_HENRY_SCHEIN_INC_3/ownership.html +271 -0
- downloads_2025_onwards/1000228_2025-02-21_HENRY_SCHEIN_INC_3/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_10-K/hsic-20241228.htm +129 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_10-K/hsic-20241228.pdf +0 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_10-K/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_3A/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_3A/ownership.html +227 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_3A/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_8-K/hsic-20250225.htm +129 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_8-K/hsic-20250225.pdf +0 -0
- downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_8-K/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-04_HENRY_SCHEIN_INC_4/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-04_HENRY_SCHEIN_INC_4/ownership.html +288 -0
- downloads_2025_onwards/1000228_2025-03-04_HENRY_SCHEIN_INC_4/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-03-06_HENRY_SCHEIN_INC_4/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-06_HENRY_SCHEIN_INC_4/ownership.html +308 -0
- downloads_2025_onwards/1000228_2025-03-06_HENRY_SCHEIN_INC_4/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-03-11_HENRY_SCHEIN_INC_4/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-11_HENRY_SCHEIN_INC_4/ownership.html +288 -0
- downloads_2025_onwards/1000228_2025-03-11_HENRY_SCHEIN_INC_4/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-03-14_HENRY_SCHEIN_INC_4/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-14_HENRY_SCHEIN_INC_4/ownership.html +320 -0
- downloads_2025_onwards/1000228_2025-03-14_HENRY_SCHEIN_INC_4/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-03-17_HENRY_SCHEIN_INC_4/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-17_HENRY_SCHEIN_INC_4/ownership.html +283 -0
- downloads_2025_onwards/1000228_2025-03-17_HENRY_SCHEIN_INC_4/ownership.pdf +0 -0
- downloads_2025_onwards/1000228_2025-03-20_HENRY_SCHEIN_INC_4/images/page_1.png +3 -0
- downloads_2025_onwards/1000228_2025-03-20_HENRY_SCHEIN_INC_4/ownership.html +283 -0
- downloads_2025_onwards/1000228_2025-03-20_HENRY_SCHEIN_INC_4/ownership.pdf +0 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_1.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_10.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_100.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_101.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_102.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_103.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_104.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_105.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_106.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_107.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_108.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_109.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_11.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_110.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_111.png +3 -0
- downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_112.png +3 -0
.gitattributes
CHANGED
@@ -57,3 +57,28 @@ saved_model/**/* filter=lfs diff=lfs merge=lfs -text
|
|
57 |
# Video files - compressed
|
58 |
*.mp4 filter=lfs diff=lfs merge=lfs -text
|
59 |
*.webm filter=lfs diff=lfs merge=lfs -text
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57 |
# Video files - compressed
|
58 |
*.mp4 filter=lfs diff=lfs merge=lfs -text
|
59 |
*.webm filter=lfs diff=lfs merge=lfs -text
|
60 |
+
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
61 |
+
downloads_2025_onwards/1000249_2025-03-13_FIRST_EAGLE_VARIABLE_FUNDS_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
62 |
+
downloads_2025_onwards/1001085_2025-02-27_BROOKFIELD_Corp_ON_SUPPL/tm257665d1_suppl.pdf filter=lfs diff=lfs merge=lfs -text
|
63 |
+
downloads_2025_onwards/1001085_2025-02-28_BROOKFIELD_Corp_ON_SUPPL/tm257665d5_suppl.pdf filter=lfs diff=lfs merge=lfs -text
|
64 |
+
downloads_2025_onwards/1002242_2025-01-03_ENI_SPA_6-K/form6k-33342_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
65 |
+
downloads_2025_onwards/1002242_2025-01-08_ENI_SPA_6-K/form6k-33364_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
66 |
+
downloads_2025_onwards/1002242_2025-01-15_ENI_SPA_6-K/form6k-33400_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
67 |
+
downloads_2025_onwards/1002242_2025-01-22_ENI_SPA_6-K/form6k-33431_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
68 |
+
downloads_2025_onwards/1002242_2025-01-29_ENI_SPA_6-K/form6k-33462_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
69 |
+
downloads_2025_onwards/1002242_2025-02-05_ENI_SPA_6-K/form6k-33497_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
70 |
+
downloads_2025_onwards/1002242_2025-02-12_ENI_SPA_6-K/form6k-33550_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
71 |
+
downloads_2025_onwards/1002242_2025-02-19_ENI_SPA_6-K/form6k-33598_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
72 |
+
downloads_2025_onwards/1002242_2025-03-04_ENI_SPA_6-K/form6k-33689_eni.pdf filter=lfs diff=lfs merge=lfs -text
|
73 |
+
downloads_2025_onwards/1002788_2025-02-04_BANCA_MONTE_DEI_PASCHI_DI_SIENA_SPA_425/pr_notice.pdf filter=lfs diff=lfs merge=lfs -text
|
74 |
+
downloads_2025_onwards/1002910_2025-02-28_AMEREN_CORP_424B2/tm257643-3_424b2.pdf filter=lfs diff=lfs merge=lfs -text
|
75 |
+
downloads_2025_onwards/100334_2025-01-08_AMERICAN_CENTURY_MUTUAL_FUNDS_INC_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
76 |
+
downloads_2025_onwards/100334_2025-03-21_AMERICAN_CENTURY_MUTUAL_FUNDS_INC_NPORT-P/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
77 |
+
downloads_2025_onwards/1003509_2025-01-30_AMERICAN_EXPRESS_CREDIT_ACCOUNT_MASTER_TRUST_424H/d764677d424h.pdf filter=lfs diff=lfs merge=lfs -text
|
78 |
+
downloads_2025_onwards/1003509_2025-02-05_AMERICAN_EXPRESS_CREDIT_ACCOUNT_MASTER_TRUST_424B5/d764677d424b5.pdf filter=lfs diff=lfs merge=lfs -text
|
79 |
+
downloads_2025_onwards/1004156_2025-03-05_ARAUCO__CONSTITUTION_PULP_INC_6-K/arr017_6k.pdf filter=lfs diff=lfs merge=lfs -text
|
80 |
+
downloads_2025_onwards/1004158_2025-03-27_GS_MORTGAGE_SECURITIES_CORP_II_SF-3/n4954_x1-sf3.pdf filter=lfs diff=lfs merge=lfs -text
|
81 |
+
downloads_2025_onwards/1004434_2025-02-28_AFFILIATED_MANAGERS_GROUP_INC_S-3ASR/d913356ds3asr.pdf filter=lfs diff=lfs merge=lfs -text
|
82 |
+
downloads_2025_onwards/1005007_2025-01-10_Banc_of_America_Merrill_Lynch_Commercial_Mortgage_Inc_SF-3A/n4686_x3-sf3a1.pdf filter=lfs diff=lfs merge=lfs -text
|
83 |
+
downloads_2025_onwards/1006373_2025-03-03_DEUTSCHE_DWS_INVESTMENTS_VIT_FUNDS_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
84 |
+
downloads_2025_onwards/1006415_2025-01-13_HARTFORD_MUTUAL_FUNDS_INC_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
downloads_2025_onwards/1000228_2025-02-05_HENRY_SCHEIN_INC_3/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-02-05_HENRY_SCHEIN_INC_3/ownership.html
ADDED
@@ -0,0 +1,226 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
3</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 3
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4"><tr>
|
37 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td>
|
38 |
+
<td rowspan="1" width="60%" valign="middle" align="center">
|
39 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
40 |
+
</td>
|
41 |
+
<td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
42 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
43 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
44 |
+
<tr>
|
45 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
46 |
+
<td class="SmallFormTextR">3235-0104</td>
|
47 |
+
</tr>
|
48 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
49 |
+
<tr>
|
50 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
51 |
+
<td class="SmallFormTextR">0.5</td>
|
52 |
+
</tr>
|
53 |
+
</table></td></tr>
|
54 |
+
</table></td>
|
55 |
+
</tr></table>
|
56 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
57 |
+
<tr>
|
58 |
+
<td rowspan="3" width="30%" valign="top">
|
59 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001496182">HOMBACH ROBERT J.</a></td></tr></table>
|
60 |
+
<hr width="98%">
|
61 |
+
<table border="0" width="100%"><tr>
|
62 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
63 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
64 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
65 |
+
</tr></table>
|
66 |
+
<table border="0" width="100%">
|
67 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
68 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
69 |
+
</table>
|
70 |
+
<hr width="98%">
|
71 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
72 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
73 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
74 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
75 |
+
</tr></table>
|
76 |
+
<hr width="98%">
|
77 |
+
<table border="0" width="100%"><tr>
|
78 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
79 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
80 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
81 |
+
</tr></table>
|
82 |
+
</td>
|
83 |
+
<td rowspan="3" width="15%" valign="top">
|
84 |
+
<span class="MedSmallFormText">2. Date of Event Requiring Statement
|
85 |
+
(Month/Day/Year)</span><br><span class="FormData">01/29/2025</span>
|
86 |
+
</td>
|
87 |
+
<td valign="top" colspan="2">
|
88 |
+
<span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
|
89 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
90 |
+
[ <span class="FormData">HSIC</span> ]
|
91 |
+
</td>
|
92 |
+
</tr>
|
93 |
+
<tr>
|
94 |
+
<td rowspan="2" width="30%" valign="top">
|
95 |
+
<span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
|
96 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
97 |
+
<tr>
|
98 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
99 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
100 |
+
<td width="15%" align="center"></td>
|
101 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
102 |
+
</tr>
|
103 |
+
<tr>
|
104 |
+
<td align="center"></td>
|
105 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
106 |
+
<td align="center"></td>
|
107 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
108 |
+
</tr>
|
109 |
+
<tr>
|
110 |
+
<td width="15%" align="center"></td>
|
111 |
+
<td width="35%" align="left" style="color: blue"></td>
|
112 |
+
<td width="15%" align="center"></td>
|
113 |
+
<td width="35%" align="left" style="color: blue"></td>
|
114 |
+
</tr>
|
115 |
+
</table>
|
116 |
+
</td>
|
117 |
+
<td valign="top">
|
118 |
+
<span class="MedSmallFormText">5. If Amendment, Date of Original Filed
|
119 |
+
(Month/Day/Year)</span><br>
|
120 |
+
</td>
|
121 |
+
</tr>
|
122 |
+
<tr><td valign="top">
|
123 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
124 |
+
</span><table border="0" width="100%">
|
125 |
+
<tr>
|
126 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
127 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
128 |
+
</tr>
|
129 |
+
<tr>
|
130 |
+
<td width="15%" align="center"></td>
|
131 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
132 |
+
</tr>
|
133 |
+
</table>
|
134 |
+
</td></tr>
|
135 |
+
</table>
|
136 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
137 |
+
<thead>
|
138 |
+
<tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr>
|
139 |
+
<tr>
|
140 |
+
<th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
141 |
+
4)
|
142 |
+
</th>
|
143 |
+
<th width="19%" valign="top" align="left" class="MedSmallFormText">2.
|
144 |
+
Amount of Securities Beneficially Owned (Instr.
|
145 |
+
4)
|
146 |
+
</th>
|
147 |
+
<th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
148 |
+
5)
|
149 |
+
</th>
|
150 |
+
<th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr.
|
151 |
+
5)
|
152 |
+
</th>
|
153 |
+
</tr>
|
154 |
+
</thead>
|
155 |
+
<tbody><tr>
|
156 |
+
<td align="left"><span class="FormData">No Securities Beneficially Owned</span></td>
|
157 |
+
<td align="center"><span class="FormData">0</span></td>
|
158 |
+
<td align="center"><span class="FormData">D</span></td>
|
159 |
+
<td align="left"></td>
|
160 |
+
</tr></tbody>
|
161 |
+
</table>
|
162 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
163 |
+
<tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC">
|
164 |
+
<b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
165 |
+
</th></tr>
|
166 |
+
<tr>
|
167 |
+
<th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr.
|
168 |
+
4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date
|
171 |
+
(Month/Day/Year)</th>
|
172 |
+
<th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr.
|
173 |
+
4)
|
174 |
+
</th>
|
175 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
|
176 |
+
</th>
|
177 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
178 |
+
5)
|
179 |
+
</th>
|
180 |
+
<th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr.
|
181 |
+
5)
|
182 |
+
</th>
|
183 |
+
</tr>
|
184 |
+
<tr>
|
185 |
+
<th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th>
|
186 |
+
<th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th>
|
187 |
+
<th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th>
|
188 |
+
<th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th>
|
189 |
+
</tr>
|
190 |
+
</thead></table>
|
191 |
+
<table border="0" width="100%">
|
192 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
193 |
+
<tr><td class="FormText"><b>Remarks:</b></td></tr>
|
194 |
+
<tr><td class="FootnoteData">See attached Exhibit 24 - Limited Power of Attorney</td></tr>
|
195 |
+
</table>
|
196 |
+
<table width="100%" border="0">
|
197 |
+
<tr>
|
198 |
+
<td width="60%"></td>
|
199 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Robert J. Hombach)</span></u></td>
|
200 |
+
<td width="20%"><u><span class="FormData">02/05/2025</span></u></td>
|
201 |
+
</tr>
|
202 |
+
<tr>
|
203 |
+
<td></td>
|
204 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
205 |
+
<td class="MedSmallFormText">Date</td>
|
206 |
+
</tr>
|
207 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
208 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
209 |
+
<i>see</i>
|
210 |
+
|
211 |
+
Instruction
|
212 |
+
5
|
213 |
+
|
214 |
+
(b)(v).</td></tr>
|
215 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
216 |
+
<i>See</i>
|
217 |
+
|
218 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
219 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
220 |
+
<i>see</i>
|
221 |
+
|
222 |
+
Instruction 6 for procedure.</td></tr>
|
223 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
224 |
+
</table>
|
225 |
+
</body>
|
226 |
+
</html>
|
downloads_2025_onwards/1000228_2025-02-05_HENRY_SCHEIN_INC_3/ownership.pdf
ADDED
Binary file (41.4 kB). View file
|
|
downloads_2025_onwards/1000228_2025-02-21_HENRY_SCHEIN_INC_3/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-02-21_HENRY_SCHEIN_INC_3/ownership.html
ADDED
@@ -0,0 +1,271 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
3</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 3
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4"><tr>
|
37 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td>
|
38 |
+
<td rowspan="1" width="60%" valign="middle" align="center">
|
39 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
40 |
+
</td>
|
41 |
+
<td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
42 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
43 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
44 |
+
<tr>
|
45 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
46 |
+
<td class="SmallFormTextR">3235-0104</td>
|
47 |
+
</tr>
|
48 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
49 |
+
<tr>
|
50 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
51 |
+
<td class="SmallFormTextR">0.5</td>
|
52 |
+
</tr>
|
53 |
+
</table></td></tr>
|
54 |
+
</table></td>
|
55 |
+
</tr></table>
|
56 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
57 |
+
<tr>
|
58 |
+
<td rowspan="3" width="30%" valign="top">
|
59 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0002057014">Popeck Thomas C</a></td></tr></table>
|
60 |
+
<hr width="98%">
|
61 |
+
<table border="0" width="100%"><tr>
|
62 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
63 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
64 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
65 |
+
</tr></table>
|
66 |
+
<table border="0" width="100%">
|
67 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
68 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
69 |
+
</table>
|
70 |
+
<hr width="98%">
|
71 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
72 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
73 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
74 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
75 |
+
</tr></table>
|
76 |
+
<hr width="98%">
|
77 |
+
<table border="0" width="100%"><tr>
|
78 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
79 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
80 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
81 |
+
</tr></table>
|
82 |
+
</td>
|
83 |
+
<td rowspan="3" width="15%" valign="top">
|
84 |
+
<span class="MedSmallFormText">2. Date of Event Requiring Statement
|
85 |
+
(Month/Day/Year)</span><br><span class="FormData">02/12/2025</span>
|
86 |
+
</td>
|
87 |
+
<td valign="top" colspan="2">
|
88 |
+
<span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
|
89 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
90 |
+
[ <span class="FormData">HSIC</span> ]
|
91 |
+
</td>
|
92 |
+
</tr>
|
93 |
+
<tr>
|
94 |
+
<td rowspan="2" width="30%" valign="top">
|
95 |
+
<span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
|
96 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
97 |
+
<tr>
|
98 |
+
<td width="15%" align="center"></td>
|
99 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
100 |
+
<td width="15%" align="center"></td>
|
101 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
102 |
+
</tr>
|
103 |
+
<tr>
|
104 |
+
<td align="center"><span class="FormData">X</span></td>
|
105 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
106 |
+
<td align="center"></td>
|
107 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
108 |
+
</tr>
|
109 |
+
<tr>
|
110 |
+
<td width="15%" align="center"></td>
|
111 |
+
<td width="35%" align="left" style="color: blue">CEO, Henry Schein Products</td>
|
112 |
+
<td width="15%" align="center"></td>
|
113 |
+
<td width="35%" align="left" style="color: blue"></td>
|
114 |
+
</tr>
|
115 |
+
</table>
|
116 |
+
</td>
|
117 |
+
<td valign="top">
|
118 |
+
<span class="MedSmallFormText">5. If Amendment, Date of Original Filed
|
119 |
+
(Month/Day/Year)</span><br>
|
120 |
+
</td>
|
121 |
+
</tr>
|
122 |
+
<tr><td valign="top">
|
123 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
124 |
+
</span><table border="0" width="100%">
|
125 |
+
<tr>
|
126 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
127 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
128 |
+
</tr>
|
129 |
+
<tr>
|
130 |
+
<td width="15%" align="center"></td>
|
131 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
132 |
+
</tr>
|
133 |
+
</table>
|
134 |
+
</td></tr>
|
135 |
+
</table>
|
136 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
137 |
+
<thead>
|
138 |
+
<tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr>
|
139 |
+
<tr>
|
140 |
+
<th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
141 |
+
4)
|
142 |
+
</th>
|
143 |
+
<th width="19%" valign="top" align="left" class="MedSmallFormText">2.
|
144 |
+
Amount of Securities Beneficially Owned (Instr.
|
145 |
+
4)
|
146 |
+
</th>
|
147 |
+
<th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
148 |
+
5)
|
149 |
+
</th>
|
150 |
+
<th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr.
|
151 |
+
5)
|
152 |
+
</th>
|
153 |
+
</tr>
|
154 |
+
</thead>
|
155 |
+
<tbody><tr>
|
156 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
157 |
+
<td align="center">
|
158 |
+
<span class="FormData">16,042</span><span class="FootnoteData"><sup>(1)</sup></span>
|
159 |
+
</td>
|
160 |
+
<td align="center"><span class="FormData">D</span></td>
|
161 |
+
<td align="left"></td>
|
162 |
+
</tr></tbody>
|
163 |
+
</table>
|
164 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
165 |
+
<thead>
|
166 |
+
<tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC">
|
167 |
+
<b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
168 |
+
</th></tr>
|
169 |
+
<tr>
|
170 |
+
<th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date
|
174 |
+
(Month/Day/Year)</th>
|
175 |
+
<th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr.
|
176 |
+
4)
|
177 |
+
</th>
|
178 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
|
179 |
+
</th>
|
180 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
181 |
+
5)
|
182 |
+
</th>
|
183 |
+
<th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr.
|
184 |
+
5)
|
185 |
+
</th>
|
186 |
+
</tr>
|
187 |
+
<tr>
|
188 |
+
<th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th>
|
189 |
+
<th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th>
|
190 |
+
<th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th>
|
191 |
+
<th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th>
|
192 |
+
</tr>
|
193 |
+
</thead>
|
194 |
+
<tbody>
|
195 |
+
<tr>
|
196 |
+
<td align="left">
|
197 |
+
<span class="FormData">Stock Option (Right to Buy)</span><span class="FootnoteData"><sup>(2)</sup></span>
|
198 |
+
</td>
|
199 |
+
<td align="center">
|
200 |
+
<span class="SmallFormData">
|
201 |
+
|
202 |
+
</span><span class="FootnoteData"><sup>(3)</sup></span>
|
203 |
+
</td>
|
204 |
+
<td align="center"><span class="SmallFormData">03/03/2031</span></td>
|
205 |
+
<td align="center"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
206 |
+
<td align="center"><span class="FormData">2,603</span></td>
|
207 |
+
<td align="center">
|
208 |
+
<span class="FormText">$</span><span class="FormData">62.71</span>
|
209 |
+
</td>
|
210 |
+
<td align="center"><span class="FormData">D</span></td>
|
211 |
+
<td align="left"></td>
|
212 |
+
</tr>
|
213 |
+
<tr>
|
214 |
+
<td align="left">
|
215 |
+
<span class="FormData">Stock Option (Right to Buy)</span><span class="FootnoteData"><sup>(2)</sup></span>
|
216 |
+
</td>
|
217 |
+
<td align="center">
|
218 |
+
<span class="SmallFormData">
|
219 |
+
|
220 |
+
</span><span class="FootnoteData"><sup>(3)</sup></span>
|
221 |
+
</td>
|
222 |
+
<td align="center"><span class="SmallFormData">03/16/2032</span></td>
|
223 |
+
<td align="center"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
224 |
+
<td align="center"><span class="FormData">1,720</span></td>
|
225 |
+
<td align="center">
|
226 |
+
<span class="FormText">$</span><span class="FormData">86.27</span>
|
227 |
+
</td>
|
228 |
+
<td align="center"><span class="FormData">D</span></td>
|
229 |
+
<td align="left"></td>
|
230 |
+
</tr>
|
231 |
+
</tbody>
|
232 |
+
</table>
|
233 |
+
<table border="0" width="100%">
|
234 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
235 |
+
<tr><td class="FootnoteData">1. Restricted stock units ("RSUs") pursuant to the Issuer's 2020 Stock Incentive Plan. 6,081 RSUs will vest subject to (x) Issuer's achievement of a specified perf. goal and (y) reporting person's continued perf. of services for Issuer. 9,961 RSUs will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for Issuer. With respect to perf. based RSUs, if the continued service requirement is satisfied and achievement of the perf. goal (x) exceeds 100% of target, Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the perf. goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to Issuer shares of common stock in an amount that corresponds to the incremental percentage of the perf. goal achieved that is below 100% of target.</td></tr>
|
236 |
+
<tr><td class="FootnoteData">2. Acquired pursuant to the Issuer's 2020 Stock Incentive Plan.</td></tr>
|
237 |
+
<tr><td class="FootnoteData">3. Subject to certain exceptions, the options vest and/or vested in three equal installments on each of the first, second and third anniversary of the grant date, subject to reporting person's continued performance of services for the Issuer.</td></tr>
|
238 |
+
<tr><td class="FormText"><b>Remarks:</b></td></tr>
|
239 |
+
<tr><td class="FootnoteData">See Exhibit 24 - Limited Power of Attorney</td></tr>
|
240 |
+
</table>
|
241 |
+
<table width="100%" border="0">
|
242 |
+
<tr>
|
243 |
+
<td width="60%"></td>
|
244 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as Attorney-in-Fact for Thomas C. Popeck)</span></u></td>
|
245 |
+
<td width="20%"><u><span class="FormData">02/21/2025</span></u></td>
|
246 |
+
</tr>
|
247 |
+
<tr>
|
248 |
+
<td></td>
|
249 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
250 |
+
<td class="MedSmallFormText">Date</td>
|
251 |
+
</tr>
|
252 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
253 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
254 |
+
<i>see</i>
|
255 |
+
|
256 |
+
Instruction
|
257 |
+
5
|
258 |
+
|
259 |
+
(b)(v).</td></tr>
|
260 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
261 |
+
<i>See</i>
|
262 |
+
|
263 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
264 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
265 |
+
<i>see</i>
|
266 |
+
|
267 |
+
Instruction 6 for procedure.</td></tr>
|
268 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
269 |
+
</table>
|
270 |
+
</body>
|
271 |
+
</html>
|
downloads_2025_onwards/1000228_2025-02-21_HENRY_SCHEIN_INC_3/ownership.pdf
ADDED
Binary file (45.9 kB). View file
|
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_10-K/hsic-20241228.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_10-K/hsic-20241228.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_10-K/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_3A/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_3A/ownership.html
ADDED
@@ -0,0 +1,227 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
3/A</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 3
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4"><tr>
|
37 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td>
|
38 |
+
<td rowspan="1" width="60%" valign="middle" align="center">
|
39 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
40 |
+
</td>
|
41 |
+
<td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
42 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
43 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
44 |
+
<tr>
|
45 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
46 |
+
<td class="SmallFormTextR">3235-0104</td>
|
47 |
+
</tr>
|
48 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
49 |
+
<tr>
|
50 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
51 |
+
<td class="SmallFormTextR">0.5</td>
|
52 |
+
</tr>
|
53 |
+
</table></td></tr>
|
54 |
+
</table></td>
|
55 |
+
</tr></table>
|
56 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
57 |
+
<tr>
|
58 |
+
<td rowspan="3" width="30%" valign="top">
|
59 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0002057014">Popeck Thomas C</a></td></tr></table>
|
60 |
+
<hr width="98%">
|
61 |
+
<table border="0" width="100%"><tr>
|
62 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
63 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
64 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
65 |
+
</tr></table>
|
66 |
+
<table border="0" width="100%">
|
67 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
68 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
69 |
+
</table>
|
70 |
+
<hr width="98%">
|
71 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
72 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
73 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
74 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
75 |
+
</tr></table>
|
76 |
+
<hr width="98%">
|
77 |
+
<table border="0" width="100%"><tr>
|
78 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
79 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
80 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
81 |
+
</tr></table>
|
82 |
+
</td>
|
83 |
+
<td rowspan="3" width="15%" valign="top">
|
84 |
+
<span class="MedSmallFormText">2. Date of Event Requiring Statement
|
85 |
+
(Month/Day/Year)</span><br><span class="FormData">02/12/2025</span>
|
86 |
+
</td>
|
87 |
+
<td valign="top" colspan="2">
|
88 |
+
<span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
|
89 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
90 |
+
[ <span class="FormData">HSIC</span> ]
|
91 |
+
</td>
|
92 |
+
</tr>
|
93 |
+
<tr>
|
94 |
+
<td rowspan="2" width="30%" valign="top">
|
95 |
+
<span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
|
96 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
97 |
+
<tr>
|
98 |
+
<td width="15%" align="center"></td>
|
99 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
100 |
+
<td width="15%" align="center"></td>
|
101 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
102 |
+
</tr>
|
103 |
+
<tr>
|
104 |
+
<td align="center"><span class="FormData">X</span></td>
|
105 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
106 |
+
<td align="center"></td>
|
107 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
108 |
+
</tr>
|
109 |
+
<tr>
|
110 |
+
<td width="15%" align="center"></td>
|
111 |
+
<td width="35%" align="left" style="color: blue">CEO, Henry Schein Products</td>
|
112 |
+
<td width="15%" align="center"></td>
|
113 |
+
<td width="35%" align="left" style="color: blue"></td>
|
114 |
+
</tr>
|
115 |
+
</table>
|
116 |
+
</td>
|
117 |
+
<td valign="top">
|
118 |
+
<span class="MedSmallFormText">5. If Amendment, Date of Original Filed
|
119 |
+
(Month/Day/Year)</span><br><span class="FormData">02/21/2025</span>
|
120 |
+
</td>
|
121 |
+
</tr>
|
122 |
+
<tr><td valign="top">
|
123 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
124 |
+
</span><table border="0" width="100%">
|
125 |
+
<tr>
|
126 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
127 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
128 |
+
</tr>
|
129 |
+
<tr>
|
130 |
+
<td width="15%" align="center"></td>
|
131 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
132 |
+
</tr>
|
133 |
+
</table>
|
134 |
+
</td></tr>
|
135 |
+
</table>
|
136 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
137 |
+
<thead>
|
138 |
+
<tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr>
|
139 |
+
<tr>
|
140 |
+
<th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
141 |
+
4)
|
142 |
+
</th>
|
143 |
+
<th width="19%" valign="top" align="left" class="MedSmallFormText">2.
|
144 |
+
Amount of Securities Beneficially Owned (Instr.
|
145 |
+
4)
|
146 |
+
</th>
|
147 |
+
<th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
148 |
+
5)
|
149 |
+
</th>
|
150 |
+
<th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr.
|
151 |
+
5)
|
152 |
+
</th>
|
153 |
+
</tr>
|
154 |
+
</thead>
|
155 |
+
<tbody><tr>
|
156 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
157 |
+
<td align="center">
|
158 |
+
<span class="FormData">23,640</span><span class="FootnoteData"><sup>(1)</sup></span>
|
159 |
+
</td>
|
160 |
+
<td align="center"><span class="FormData">D</span></td>
|
161 |
+
<td align="left"></td>
|
162 |
+
</tr></tbody>
|
163 |
+
</table>
|
164 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
165 |
+
<tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC">
|
166 |
+
<b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
167 |
+
</th></tr>
|
168 |
+
<tr>
|
169 |
+
<th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr.
|
170 |
+
4)
|
171 |
+
</th>
|
172 |
+
<th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date
|
173 |
+
(Month/Day/Year)</th>
|
174 |
+
<th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr.
|
175 |
+
4)
|
176 |
+
</th>
|
177 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
|
178 |
+
</th>
|
179 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
180 |
+
5)
|
181 |
+
</th>
|
182 |
+
<th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr.
|
183 |
+
5)
|
184 |
+
</th>
|
185 |
+
</tr>
|
186 |
+
<tr>
|
187 |
+
<th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th>
|
188 |
+
<th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th>
|
189 |
+
<th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th>
|
190 |
+
<th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th>
|
191 |
+
</tr>
|
192 |
+
</thead></table>
|
193 |
+
<table border="0" width="100%">
|
194 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
195 |
+
<tr><td class="FootnoteData">1. The original Form 3 filed on February 21, 2025 is being amended solely to correct the number of restricted stock units ("RSUs") held by the Reporting Person. 9,880 RSUs will vest subject to (x) Issuer's achievement of a specified performance goal and (y) reporting person's continued performance of services for Issuer. 13,760 RSUs will vest subject to (x) passage of a specified period of time and (y) reporting person's continued performance of services for Issuer.</td></tr>
|
196 |
+
</table>
|
197 |
+
<table width="100%" border="0">
|
198 |
+
<tr>
|
199 |
+
<td width="60%"></td>
|
200 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Thomas C. Popeck)</span></u></td>
|
201 |
+
<td width="20%"><u><span class="FormData">02/25/2025</span></u></td>
|
202 |
+
</tr>
|
203 |
+
<tr>
|
204 |
+
<td></td>
|
205 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
206 |
+
<td class="MedSmallFormText">Date</td>
|
207 |
+
</tr>
|
208 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
209 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
210 |
+
<i>see</i>
|
211 |
+
|
212 |
+
Instruction
|
213 |
+
5
|
214 |
+
|
215 |
+
(b)(v).</td></tr>
|
216 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
217 |
+
<i>See</i>
|
218 |
+
|
219 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
220 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
221 |
+
<i>see</i>
|
222 |
+
|
223 |
+
Instruction 6 for procedure.</td></tr>
|
224 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
225 |
+
</table>
|
226 |
+
</body>
|
227 |
+
</html>
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_3A/ownership.pdf
ADDED
Binary file (43 kB). View file
|
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_8-K/hsic-20250225.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_8-K/hsic-20250225.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards/1000228_2025-02-25_HENRY_SCHEIN_INC_8-K/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-04_HENRY_SCHEIN_INC_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-04_HENRY_SCHEIN_INC_4/ownership.html
ADDED
@@ -0,0 +1,288 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0002025230">Albertini Andrea</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
81 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
86 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
87 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
99 |
+
[ <span class="FormData">HSIC</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">CEO, Global Dist. & Tech.</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">03/03/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
187 |
+
<td align="center"><span class="FormData">03/03/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">F</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center">
|
192 |
+
<span class="FormData">1,053</span><span class="FootnoteData"><sup>(1)</sup></span>
|
193 |
+
</td>
|
194 |
+
<td align="center"><span class="FormData">D</span></td>
|
195 |
+
<td align="center">
|
196 |
+
<span class="FormText">$</span><span class="FormData">70.81</span>
|
197 |
+
</td>
|
198 |
+
<td align="center"><span class="FormData">48,813</span></td>
|
199 |
+
<td align="center"><span class="FormData">D</span></td>
|
200 |
+
<td align="left"></td>
|
201 |
+
</tr></tbody>
|
202 |
+
</table>
|
203 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
204 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
205 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
206 |
+
</th></tr>
|
207 |
+
<tr>
|
208 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
209 |
+
3)
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
212 |
+
</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
216 |
+
(Month/Day/Year)</th>
|
217 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
218 |
+
8)
|
219 |
+
</th>
|
220 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
221 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
222 |
+
3, 4 and 5)
|
223 |
+
</th>
|
224 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
225 |
+
(Month/Day/Year)</th>
|
226 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
227 |
+
3 and 4)
|
228 |
+
</th>
|
229 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
230 |
+
5)
|
231 |
+
</th>
|
232 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
233 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
234 |
+
4)
|
235 |
+
</th>
|
236 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
237 |
+
4)
|
238 |
+
</th>
|
239 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
240 |
+
4)
|
241 |
+
</th>
|
242 |
+
</tr>
|
243 |
+
<tr>
|
244 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
245 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
247 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
248 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
249 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
250 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
251 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
252 |
+
</tr>
|
253 |
+
</thead></table>
|
254 |
+
<table border="0" width="100%">
|
255 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
256 |
+
<tr><td class="FootnoteData">1. Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's 2021 grant of time-based restricted stock units.</td></tr>
|
257 |
+
</table>
|
258 |
+
<table width="100%" border="0">
|
259 |
+
<tr>
|
260 |
+
<td width="60%"></td>
|
261 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Andrea Albertini)</span></u></td>
|
262 |
+
<td width="20%"><u><span class="FormData">03/04/2025</span></u></td>
|
263 |
+
</tr>
|
264 |
+
<tr>
|
265 |
+
<td></td>
|
266 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
267 |
+
<td class="MedSmallFormText">Date</td>
|
268 |
+
</tr>
|
269 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
270 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
271 |
+
<i>see</i>
|
272 |
+
|
273 |
+
Instruction
|
274 |
+
4
|
275 |
+
|
276 |
+
(b)(v).</td></tr>
|
277 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
278 |
+
<i>See</i>
|
279 |
+
|
280 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
281 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
282 |
+
<i>see</i>
|
283 |
+
|
284 |
+
Instruction 6 for procedure.</td></tr>
|
285 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
286 |
+
</table>
|
287 |
+
</body>
|
288 |
+
</html>
|
downloads_2025_onwards/1000228_2025-03-04_HENRY_SCHEIN_INC_4/ownership.pdf
ADDED
Binary file (47.3 kB). View file
|
|
downloads_2025_onwards/1000228_2025-03-06_HENRY_SCHEIN_INC_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-06_HENRY_SCHEIN_INC_4/ownership.html
ADDED
@@ -0,0 +1,308 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001580247">ALI MOHAMAD</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
81 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
86 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
87 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
99 |
+
[ <span class="FormData">HSIC</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue"></td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">03/04/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody>
|
186 |
+
<tr>
|
187 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
188 |
+
<td align="center"><span class="FormData">03/04/2025</span></td>
|
189 |
+
<td align="center"></td>
|
190 |
+
<td align="center"><span class="SmallFormData">F</span></td>
|
191 |
+
<td align="center"></td>
|
192 |
+
<td align="center">
|
193 |
+
<span class="FormData">572</span><span class="FootnoteData"><sup>(1)</sup></span>
|
194 |
+
</td>
|
195 |
+
<td align="center"><span class="FormData">D</span></td>
|
196 |
+
<td align="center">
|
197 |
+
<span class="FormText">$</span><span class="FormData">70.31</span>
|
198 |
+
</td>
|
199 |
+
<td align="center"><span class="FormData">9,654</span></td>
|
200 |
+
<td align="center"><span class="FormData">D</span></td>
|
201 |
+
<td align="left"></td>
|
202 |
+
</tr>
|
203 |
+
<tr>
|
204 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
205 |
+
<td align="center"><span class="FormData">03/04/2025</span></td>
|
206 |
+
<td align="center"></td>
|
207 |
+
<td align="center"><span class="SmallFormData">A</span></td>
|
208 |
+
<td align="center"></td>
|
209 |
+
<td align="center">
|
210 |
+
<span class="FormData">2,844</span><span class="FootnoteData"><sup>(2)</sup></span>
|
211 |
+
</td>
|
212 |
+
<td align="center"><span class="FormData">A</span></td>
|
213 |
+
<td align="center">
|
214 |
+
<span class="FormText">$</span><span class="FormData">0.00</span>
|
215 |
+
</td>
|
216 |
+
<td align="center"><span class="FormData">12,498</span></td>
|
217 |
+
<td align="center"><span class="FormData">D</span></td>
|
218 |
+
<td align="left"></td>
|
219 |
+
</tr>
|
220 |
+
</tbody>
|
221 |
+
</table>
|
222 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
223 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
224 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
225 |
+
</th></tr>
|
226 |
+
<tr>
|
227 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
228 |
+
3)
|
229 |
+
</th>
|
230 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
231 |
+
</th>
|
232 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
233 |
+
(Month/Day/Year)</th>
|
234 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
235 |
+
(Month/Day/Year)</th>
|
236 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
237 |
+
8)
|
238 |
+
</th>
|
239 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
240 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
241 |
+
3, 4 and 5)
|
242 |
+
</th>
|
243 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
244 |
+
(Month/Day/Year)</th>
|
245 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
246 |
+
3 and 4)
|
247 |
+
</th>
|
248 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
249 |
+
5)
|
250 |
+
</th>
|
251 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
252 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
253 |
+
4)
|
254 |
+
</th>
|
255 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
256 |
+
4)
|
257 |
+
</th>
|
258 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
259 |
+
4)
|
260 |
+
</th>
|
261 |
+
</tr>
|
262 |
+
<tr>
|
263 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
264 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
265 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
266 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
267 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
268 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
269 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
270 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
271 |
+
</tr>
|
272 |
+
</thead></table>
|
273 |
+
<table border="0" width="100%">
|
274 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
275 |
+
<tr><td class="FootnoteData">1. Represents the surrender of shares to the Issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's 2024 grant of time-based restricted stock units.</td></tr>
|
276 |
+
<tr><td class="FootnoteData">2. Acquired pursuant to the Issuer's 2023 Non-Employee Director Stock Incentive Plan. Subject to certain exceptions, such restricted stock/units will vest subject to (i) the passage of a specified period of time and (i) the reporting person's continued performance of services for the Issuer.</td></tr>
|
277 |
+
</table>
|
278 |
+
<table width="100%" border="0">
|
279 |
+
<tr>
|
280 |
+
<td width="60%"></td>
|
281 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Mohamad Ali)</span></u></td>
|
282 |
+
<td width="20%"><u><span class="FormData">03/06/2025</span></u></td>
|
283 |
+
</tr>
|
284 |
+
<tr>
|
285 |
+
<td></td>
|
286 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
287 |
+
<td class="MedSmallFormText">Date</td>
|
288 |
+
</tr>
|
289 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
290 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
291 |
+
<i>see</i>
|
292 |
+
|
293 |
+
Instruction
|
294 |
+
4
|
295 |
+
|
296 |
+
(b)(v).</td></tr>
|
297 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
298 |
+
<i>See</i>
|
299 |
+
|
300 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
301 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
302 |
+
<i>see</i>
|
303 |
+
|
304 |
+
Instruction 6 for procedure.</td></tr>
|
305 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
306 |
+
</table>
|
307 |
+
</body>
|
308 |
+
</html>
|
downloads_2025_onwards/1000228_2025-03-06_HENRY_SCHEIN_INC_4/ownership.pdf
ADDED
Binary file (48.5 kB). View file
|
|
downloads_2025_onwards/1000228_2025-03-11_HENRY_SCHEIN_INC_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-11_HENRY_SCHEIN_INC_4/ownership.html
ADDED
@@ -0,0 +1,288 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0002025230">Albertini Andrea</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
81 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
86 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
87 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
99 |
+
[ <span class="FormData">HSIC</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">CEO, Global Dist. & Tech.</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">03/10/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
187 |
+
<td align="center"><span class="FormData">03/10/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">A</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center">
|
192 |
+
<span class="FormData">21,206</span><span class="FootnoteData"><sup>(1)</sup></span>
|
193 |
+
</td>
|
194 |
+
<td align="center"><span class="FormData">A</span></td>
|
195 |
+
<td align="center">
|
196 |
+
<span class="FormText">$</span><span class="FormData">0</span>
|
197 |
+
</td>
|
198 |
+
<td align="center"><span class="FormData">70,019</span></td>
|
199 |
+
<td align="center"><span class="FormData">D</span></td>
|
200 |
+
<td align="left"></td>
|
201 |
+
</tr></tbody>
|
202 |
+
</table>
|
203 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
204 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
205 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
206 |
+
</th></tr>
|
207 |
+
<tr>
|
208 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
209 |
+
3)
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
212 |
+
</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
216 |
+
(Month/Day/Year)</th>
|
217 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
218 |
+
8)
|
219 |
+
</th>
|
220 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
221 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
222 |
+
3, 4 and 5)
|
223 |
+
</th>
|
224 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
225 |
+
(Month/Day/Year)</th>
|
226 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
227 |
+
3 and 4)
|
228 |
+
</th>
|
229 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
230 |
+
5)
|
231 |
+
</th>
|
232 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
233 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
234 |
+
4)
|
235 |
+
</th>
|
236 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
237 |
+
4)
|
238 |
+
</th>
|
239 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
240 |
+
4)
|
241 |
+
</th>
|
242 |
+
</tr>
|
243 |
+
<tr>
|
244 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
245 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
247 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
248 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
249 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
250 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
251 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
252 |
+
</tr>
|
253 |
+
</thead></table>
|
254 |
+
<table border="0" width="100%">
|
255 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
256 |
+
<tr><td class="FootnoteData">1. Grant of restricted stock units (RSU) pursuant to the Issuer's 2024 Stock Incentive Plan. Subject to certain exceptions, 50% will vest subject to (x) Issuer's achievement of specified performance goals and (y) reporting person's continued perf. of services for the Issuer. 50% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for the Issuer. With respect to the performance-based RSUs, if the continued service requirement is satisfied and achievement of the perf. goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved that is below 100% of target (shortfall).</td></tr>
|
257 |
+
</table>
|
258 |
+
<table width="100%" border="0">
|
259 |
+
<tr>
|
260 |
+
<td width="60%"></td>
|
261 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Andrea Albertini)</span></u></td>
|
262 |
+
<td width="20%"><u><span class="FormData">03/11/2025</span></u></td>
|
263 |
+
</tr>
|
264 |
+
<tr>
|
265 |
+
<td></td>
|
266 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
267 |
+
<td class="MedSmallFormText">Date</td>
|
268 |
+
</tr>
|
269 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
270 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
271 |
+
<i>see</i>
|
272 |
+
|
273 |
+
Instruction
|
274 |
+
4
|
275 |
+
|
276 |
+
(b)(v).</td></tr>
|
277 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
278 |
+
<i>See</i>
|
279 |
+
|
280 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
281 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
282 |
+
<i>see</i>
|
283 |
+
|
284 |
+
Instruction 6 for procedure.</td></tr>
|
285 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
286 |
+
</table>
|
287 |
+
</body>
|
288 |
+
</html>
|
downloads_2025_onwards/1000228_2025-03-11_HENRY_SCHEIN_INC_4/ownership.pdf
ADDED
Binary file (48.7 kB). View file
|
|
downloads_2025_onwards/1000228_2025-03-14_HENRY_SCHEIN_INC_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-14_HENRY_SCHEIN_INC_4/ownership.html
ADDED
@@ -0,0 +1,320 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001008413">BERGMAN STANLEY M</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
81 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
86 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
87 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
99 |
+
[ <span class="FormData">HSIC</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">Chairman, CEO</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">03/12/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody>
|
186 |
+
<tr>
|
187 |
+
<td align="left"><span class="FormData">Common Stock par value $0.01 per shre</span></td>
|
188 |
+
<td align="center"><span class="FormData">03/12/2025</span></td>
|
189 |
+
<td align="center"></td>
|
190 |
+
<td align="center"><span class="SmallFormData">G</span></td>
|
191 |
+
<td align="center"></td>
|
192 |
+
<td align="center"><span class="FormData">950</span></td>
|
193 |
+
<td align="center"><span class="FormData">D</span></td>
|
194 |
+
<td align="center">
|
195 |
+
<span class="FormText">$</span><span class="FormData">0</span><span class="FootnoteData"><sup>(1)</sup></span>
|
196 |
+
</td>
|
197 |
+
<td align="center"><span class="FormData">353,354</span></td>
|
198 |
+
<td align="center"><span class="FormData">D</span></td>
|
199 |
+
<td align="left"></td>
|
200 |
+
</tr>
|
201 |
+
<tr>
|
202 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
203 |
+
<td align="center"></td>
|
204 |
+
<td align="center"></td>
|
205 |
+
<td align="center"></td>
|
206 |
+
<td align="center"></td>
|
207 |
+
<td align="center"></td>
|
208 |
+
<td align="center"></td>
|
209 |
+
<td align="center"></td>
|
210 |
+
<td align="center"><span class="FormData">465,961</span></td>
|
211 |
+
<td align="center"><span class="FormData">I</span></td>
|
212 |
+
<td align="left">
|
213 |
+
<span class="FormData">By Spouse</span><span class="FootnoteData"><sup>(2)</sup></span>
|
214 |
+
</td>
|
215 |
+
</tr>
|
216 |
+
<tr>
|
217 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
218 |
+
<td align="center"></td>
|
219 |
+
<td align="center"></td>
|
220 |
+
<td align="center"></td>
|
221 |
+
<td align="center"></td>
|
222 |
+
<td align="center"></td>
|
223 |
+
<td align="center"></td>
|
224 |
+
<td align="center"></td>
|
225 |
+
<td align="center"><span class="FormData">9,739</span></td>
|
226 |
+
<td align="center"><span class="FormData">I</span></td>
|
227 |
+
<td align="left">
|
228 |
+
<span class="FormData">By 401(k) Plan</span><span class="FootnoteData"><sup>(3)</sup></span>
|
229 |
+
</td>
|
230 |
+
</tr>
|
231 |
+
</tbody>
|
232 |
+
</table>
|
233 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
234 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
235 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
236 |
+
</th></tr>
|
237 |
+
<tr>
|
238 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
239 |
+
3)
|
240 |
+
</th>
|
241 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
242 |
+
</th>
|
243 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
244 |
+
(Month/Day/Year)</th>
|
245 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
246 |
+
(Month/Day/Year)</th>
|
247 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
248 |
+
8)
|
249 |
+
</th>
|
250 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
251 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
252 |
+
3, 4 and 5)
|
253 |
+
</th>
|
254 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
255 |
+
(Month/Day/Year)</th>
|
256 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
257 |
+
3 and 4)
|
258 |
+
</th>
|
259 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
260 |
+
5)
|
261 |
+
</th>
|
262 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
263 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
264 |
+
4)
|
265 |
+
</th>
|
266 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
267 |
+
4)
|
268 |
+
</th>
|
269 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
270 |
+
4)
|
271 |
+
</th>
|
272 |
+
</tr>
|
273 |
+
<tr>
|
274 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
275 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
276 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
277 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
278 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
279 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
280 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
281 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
282 |
+
</tr>
|
283 |
+
</thead></table>
|
284 |
+
<table border="0" width="100%">
|
285 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
286 |
+
<tr><td class="FootnoteData">1. Gift, not applicable.</td></tr>
|
287 |
+
<tr><td class="FootnoteData">2. Represents (i) 112,672 shares held by the Bergman Family 2010 Trust #2, of which Mrs. Bergman, Stanley M. Bergman's wife, is a co-trustee and a beneficiary; (ii) 21 shares held by Mrs.Bergman; (iii) 329,410 shares held by the Bergman Family 2010 Trust #2, LLC, of which Mrs. Bergman is a manager; and (iv) 23,858 shares held by the SBMB GST Trusts Partners LLC, of which Mrs. Bergman is a manager.</td></tr>
|
288 |
+
<tr><td class="FootnoteData">3. Reflects the reporting person's interest in equivalent shares of Henry Schein common stock held by the unitized stock fund in the Henry Schein, Inc. 401(k) Savings Plan (the "Plan"). The unitized stock fund consists of Henry Schein common stock and cash or cash equivalents. The number of shares attributed to the reporting person as a participant in the Plan and expressed as equivalent shares has been calculated based on the closing price of Henry Schein common stock on March 12, 2025.</td></tr>
|
289 |
+
</table>
|
290 |
+
<table width="100%" border="0">
|
291 |
+
<tr>
|
292 |
+
<td width="60%"></td>
|
293 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Stanley M. Bergman)</span></u></td>
|
294 |
+
<td width="20%"><u><span class="FormData">03/14/2025</span></u></td>
|
295 |
+
</tr>
|
296 |
+
<tr>
|
297 |
+
<td></td>
|
298 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
299 |
+
<td class="MedSmallFormText">Date</td>
|
300 |
+
</tr>
|
301 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
302 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
303 |
+
<i>see</i>
|
304 |
+
|
305 |
+
Instruction
|
306 |
+
4
|
307 |
+
|
308 |
+
(b)(v).</td></tr>
|
309 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
310 |
+
<i>See</i>
|
311 |
+
|
312 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
313 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
314 |
+
<i>see</i>
|
315 |
+
|
316 |
+
Instruction 6 for procedure.</td></tr>
|
317 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
318 |
+
</table>
|
319 |
+
</body>
|
320 |
+
</html>
|
downloads_2025_onwards/1000228_2025-03-14_HENRY_SCHEIN_INC_4/ownership.pdf
ADDED
Binary file (50.3 kB). View file
|
|
downloads_2025_onwards/1000228_2025-03-17_HENRY_SCHEIN_INC_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-17_HENRY_SCHEIN_INC_4/ownership.html
ADDED
@@ -0,0 +1,283 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0002025230">Albertini Andrea</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
81 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
86 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
87 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
99 |
+
[ <span class="FormData">HSIC</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">CEO, Global Dist. & Tech.</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">03/14/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
187 |
+
<td align="center"><span class="FormData">03/14/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">D</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center"><span class="FormData">2,087</span></td>
|
192 |
+
<td align="center"><span class="FormData">D</span></td>
|
193 |
+
<td align="center">
|
194 |
+
<span class="FormText">$</span><span class="FormData">0</span>
|
195 |
+
</td>
|
196 |
+
<td align="center"><span class="FormData">67,932</span></td>
|
197 |
+
<td align="center"><span class="FormData">D</span></td>
|
198 |
+
<td align="left"></td>
|
199 |
+
</tr></tbody>
|
200 |
+
</table>
|
201 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
202 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
203 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
204 |
+
</th></tr>
|
205 |
+
<tr>
|
206 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
207 |
+
3)
|
208 |
+
</th>
|
209 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
212 |
+
(Month/Day/Year)</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
216 |
+
8)
|
217 |
+
</th>
|
218 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
219 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
220 |
+
3, 4 and 5)
|
221 |
+
</th>
|
222 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
223 |
+
(Month/Day/Year)</th>
|
224 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
225 |
+
3 and 4)
|
226 |
+
</th>
|
227 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
228 |
+
5)
|
229 |
+
</th>
|
230 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
231 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
232 |
+
4)
|
233 |
+
</th>
|
234 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
235 |
+
4)
|
236 |
+
</th>
|
237 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
238 |
+
4)
|
239 |
+
</th>
|
240 |
+
</tr>
|
241 |
+
<tr>
|
242 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
243 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
244 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
245 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
247 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
248 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
249 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
250 |
+
</tr>
|
251 |
+
</thead></table>
|
252 |
+
<table border="0" width="100%"><tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr></table>
|
253 |
+
<table width="100%" border="0">
|
254 |
+
<tr>
|
255 |
+
<td width="60%"></td>
|
256 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Andrea Albertini)</span></u></td>
|
257 |
+
<td width="20%"><u><span class="FormData">03/17/2025</span></u></td>
|
258 |
+
</tr>
|
259 |
+
<tr>
|
260 |
+
<td></td>
|
261 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
262 |
+
<td class="MedSmallFormText">Date</td>
|
263 |
+
</tr>
|
264 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
265 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
266 |
+
<i>see</i>
|
267 |
+
|
268 |
+
Instruction
|
269 |
+
4
|
270 |
+
|
271 |
+
(b)(v).</td></tr>
|
272 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
273 |
+
<i>See</i>
|
274 |
+
|
275 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
276 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
277 |
+
<i>see</i>
|
278 |
+
|
279 |
+
Instruction 6 for procedure.</td></tr>
|
280 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
281 |
+
</table>
|
282 |
+
</body>
|
283 |
+
</html>
|
downloads_2025_onwards/1000228_2025-03-17_HENRY_SCHEIN_INC_4/ownership.pdf
ADDED
Binary file (46.7 kB). View file
|
|
downloads_2025_onwards/1000228_2025-03-20_HENRY_SCHEIN_INC_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000228_2025-03-20_HENRY_SCHEIN_INC_4/ownership.html
ADDED
@@ -0,0 +1,283 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001884896">Connett Bradford C</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O HENRY SCHEIN, INC.</span></td></tr>
|
81 |
+
<tr><td><span class="FormData">135 DURYEA ROAD</span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">MELVILLE</span></td>
|
86 |
+
<td width="33%"><span class="FormData">NY</span></td>
|
87 |
+
<td width="33%"><span class="FormData">11747</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001000228">HENRY SCHEIN INC</a>
|
99 |
+
[ <span class="FormData">HSIC</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">CEO, NA Distribution Group</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">03/19/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock, par value $0.01 per share</span></td>
|
187 |
+
<td align="center"><span class="FormData">03/19/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">S</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center"><span class="FormData">4,036</span></td>
|
192 |
+
<td align="center"><span class="FormData">D</span></td>
|
193 |
+
<td align="center">
|
194 |
+
<span class="FormText">$</span><span class="FormData">71.15</span>
|
195 |
+
</td>
|
196 |
+
<td align="center"><span class="FormData">62,688</span></td>
|
197 |
+
<td align="center"><span class="FormData">D</span></td>
|
198 |
+
<td align="left"></td>
|
199 |
+
</tr></tbody>
|
200 |
+
</table>
|
201 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
202 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
203 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
204 |
+
</th></tr>
|
205 |
+
<tr>
|
206 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
207 |
+
3)
|
208 |
+
</th>
|
209 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
212 |
+
(Month/Day/Year)</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
216 |
+
8)
|
217 |
+
</th>
|
218 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
219 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
220 |
+
3, 4 and 5)
|
221 |
+
</th>
|
222 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
223 |
+
(Month/Day/Year)</th>
|
224 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
225 |
+
3 and 4)
|
226 |
+
</th>
|
227 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
228 |
+
5)
|
229 |
+
</th>
|
230 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
231 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
232 |
+
4)
|
233 |
+
</th>
|
234 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
235 |
+
4)
|
236 |
+
</th>
|
237 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
238 |
+
4)
|
239 |
+
</th>
|
240 |
+
</tr>
|
241 |
+
<tr>
|
242 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
243 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
244 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
245 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
247 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
248 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
249 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
250 |
+
</tr>
|
251 |
+
</thead></table>
|
252 |
+
<table border="0" width="100%"><tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr></table>
|
253 |
+
<table width="100%" border="0">
|
254 |
+
<tr>
|
255 |
+
<td width="60%"></td>
|
256 |
+
<td width="20%"><u><span class="FormData">/s/ Jennifer Ferrero (as attorney-in-fact for Bradford C. Connett)</span></u></td>
|
257 |
+
<td width="20%"><u><span class="FormData">03/20/2025</span></u></td>
|
258 |
+
</tr>
|
259 |
+
<tr>
|
260 |
+
<td></td>
|
261 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
262 |
+
<td class="MedSmallFormText">Date</td>
|
263 |
+
</tr>
|
264 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
265 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
266 |
+
<i>see</i>
|
267 |
+
|
268 |
+
Instruction
|
269 |
+
4
|
270 |
+
|
271 |
+
(b)(v).</td></tr>
|
272 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
273 |
+
<i>See</i>
|
274 |
+
|
275 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
276 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
277 |
+
<i>see</i>
|
278 |
+
|
279 |
+
Instruction 6 for procedure.</td></tr>
|
280 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
281 |
+
</table>
|
282 |
+
</body>
|
283 |
+
</html>
|
downloads_2025_onwards/1000228_2025-03-20_HENRY_SCHEIN_INC_4/ownership.pdf
ADDED
Binary file (46.7 kB). View file
|
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_10.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_100.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_101.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_102.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_103.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_104.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_105.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_106.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_107.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_108.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_109.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_11.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_110.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_111.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards/1000249_2025-02-28_FIRST_EAGLE_VARIABLE_FUNDS_NPORT-P/images/page_112.png
ADDED
![]() |
Git LFS Details
|